BiondVax Announces Third Quarter 2015 Financial Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
BiondVax Pharma (BVXV) Reports Q3 EPS of NIS0.00
November 9, 2015 8:06 AM ESTBiondVax Pharma (NASDAQ: BVXV) reported Q3 EPS of NIS0.00, versus NIS0.03 reported last year.
For earnings history and earnings-related data on BiondVax Pharma (BVXV) click here.
... More